Feasibility Analysis & Market Diligence
Get the foundational decisions right before they become expensive to undo.
Ideal clients
- Sponsors and developers
- Health systems
- Equity investors
- Lenders
Typical outcomes
- A defensible go / no-go view, not a polished maybe
- A pro forma that survives external diligence
- A clear sequence for the next 6, 12, and 24 months
Bringing a new proton center, or any major radiation oncology investment, from idea to commissioned operation is a multi-year exercise in financial discipline, technical sequencing, and market reality. We pressure-test the foundational decisions before they become expensive to undo.
Most proton projects fail, or struggle for years, because of decisions made well before the first wall is poured. Vendor selection, site economics, partnership structure, and demand assumptions compound silently across the build cycle.
We work alongside sponsors, health systems, and capital providers to model the market, build defensible proformas, and stress-test the operating case. The output is not a generic feasibility deck. It is a clear-eyed view of what this specific project actually needs to be true to work, clinically, commercially, and operationally.
Sample scope
- Market analysis and demand assessment
- Pro forma development and financial modeling
- Catchment, payer mix, and referral physics modeling
- Vendor and site option comparisons
- Strategic planning and program scoping
- Partnership and joint-venture structuring input
Pressure-test a project in 30 seconds.
Pick a modality, dial in your payer mix, volume, and equity capital. The composite score is illustrative, not a substitute for diligence.
Particle therapy. Highest capital intensity, premium reimbursement.
Adjust any slider, the others rebalance to sum to 100%. Lock a payer to hold its share fixed.
Under 100/yr is thin; 100–200 is light; 200–300 is healthy; 300+ is great.
Benchmark for protons: up to $30M. More equity strengthens the capital structure score.
Pursue with disciplined execution.
Illustrative · not investment advice
Often engaged in combination.
Turnaround Services
Centers do not need a new strategy deck. They need someone who has lived inside one.
Growth & Referral Development
Centers do not fail because the technology underperforms. They fail because volume never shows up.
Buy-Side Advisory
Diligence built from the inside out, for investors and operators acquiring proton centers.
Most engagements start with a single, focused conversation.
Tell us where the situation is, and we'll tell you whether we're the right firm for it.